QHM-2025-7692 Carlisle Healthcare - Local Enhanced Services

The NHS North East and North Cumbria Integrated Care Board is set to award a contract under the Direct Award Process A for local enhanced healthcare services, focusing on near patient testing and drug monitoring, among others, in the Carlisle area. The process falls outside the usual procurement regulations, highlighting the use of a limited procurement method without prior publication. This contract is scheduled to start on 1 April 2025 and end on 31 March 2026, though it mentions the services have already been delivered under an implied contract.

The procurement's main category is health services, with key oversight by the Chief Delivery Officer and the Director of Finance to ensure no conflicts of interest were present. This tender presents significant opportunities for businesses involved in health services, particularly those already established in the field, given its reliance on existing service providers. It is especially suited to health service providers capable of offering specialised testing and monitoring services.

Suppliers looking to expand their portfolio in healthcare services in the UKC (United Kingdom – Cumbria) region could benefit from this contract, although the procurement method indicates no alternative providers were considered, implying the contract is likely intended for existing suppliers. The limited competition due to the procurement method underscores the potential stability this contract could offer successful bidders.